Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 1976

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1C
Chunk 1976
---
327,060  
    $1,601,255 
  
    Prepaid expenses and other current assets 
     274,749  
     368,780 
  
    Deferred offering costs 
     112,232  
     - 
  
    Total current assets 
     3,714,041  
     1,970,035 

    Deferred offering costs, net of current portion 
     500,000  
     - 
  
    Operating lease right-of-use assets 
     1,464,367  
     2,189,565 
  
    Property and equipment, net 
     528,521  
     966,702 
  
    Total assets 
    $6,206,929 
    $5,126,302 

    LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT 

    Current liabilities: 

    Accounts payable 
    $4,507,318  
    $1,671,745 
  
    Accrued liabilities 
     1,913,175  
     144,633 
  
    Common stock subscription deposit 
     -  
     1,875 
  
    Operating lease liability 
     876,392  
     769,092 
  
    Short-term notes payable, net 
     -  
     599,692 
  
    Earnout liability 
     20,000  
     - 
  
    Deemed dividend – common stock liability, 13,835 shares 
     85,500  
     - 
  
    Preferred stock warrant liability 
     -  
     320,117 
  
    Total current liabilities 
     7,402,385  
     3,507,154 

    Operating lease liability, net of current portion 
     699,107  
     1,575,499 
  
    Total liabilities 
     8,101,492  
     5,082,653 

    Commitments and contingencies 

    Convertible preferred stock, $0.0001 par value per share, issuable in series: 

    Series Seed: 5,155,703 shares authorized, issued and outstanding at December 31, 2023 
     -  
     4,077,560 
  
    Series A: 24,614,402 shares authorized,